Recent days have seen significant leadership changes at two pharmaceutical giants: UK-based GSK plc (LON: GSK) and US-based Abbott Laboratories (NYSE: ABT).
GSK Appoints Jocelyn Luo as Mix Team Leader
Jocelyn Luo has been appointed as the leader of GSK’s Mix team, reporting to Westly Yu, head of GSK’s respiratory business department. Previously, Luo served as the senior director of business innovation and regional markets at Sanofi Pasteur.
Fanny Chen Retires from Abbott; Paul Tan Takes Over
Fanny Chen, global Vice President of Abbott Core Diagnostics and General Manager of Abbott Core Diagnostics Greater China, has announced her retirement from Abbott. Paul Tan has been appointed as the Vice President of Abbott China Core Diagnostics, leading the Abbott China Core Diagnostics team.-Fineline Info & Tech
Leave a Reply